Basics
Description
- Invasive parasitic infection with both intestinal and extraintestinal manifestations
- Endemic worldwide, especially areas with poor sanitation
- Populations at risk:
- Travelers to, citizens of, and immigrants from endemic areas
- Institutionalized persons
- Practitioners of oral-anal sexual activity
- Men who have sex with men (MSM)
- HIV infected individuals
- Risk factors for increased severity of disease and complications:
- Immunocompromised: Corticosteroid use, HIV infection, malnutrition, malignancy
- Pregnancy/postpartum state
- Extremes of age
Etiology
- Entamoeba histolytica, an anaerobic, nonflagellated protozoa
- Fecal-oral transmission:
- Humans are sole reservoir.
- Ingested organisms cause invasive colitis.
- Extraintestinal spread is hematogenous.
Diagnosis
Signs and Symptoms
- Intestinal disease:
- Onset 1 wk to 1 mo postexposure
- Acute diarrhea (nondysenteric colitis):
- 80% of cases
- Afebrile
- Occult blood in stool
- Benign abdominal exam
- Classic dysentery:
- Bloody mucoid diarrhea
- Abdominal pain/benign abdominal exam
- Tenesmus
- Weight loss
- Fever (rare)
- Fulminant colitis:
- Toxic-appearing patient
- Rigid abdomen (25%)
- Fever
- Severe bloody diarrhea
- Rapid progression to perforated bowel and frank peritonitis
- >40% mortality
- Toxic megacolon:
- Toxic-appearing patient
- Profuse diarrhea (>10 stools per day)
- Fever
- Distended, tympanitic abdomen with signs of peritonitis
- Associated with corticosteroid use
- High mortality
- Ameboma:
- Intraluminal granulated mass
- Tender palpable mass on exam
- Amebic strictures:
- Owing to chronic inflammation/scarring
- Crampy abdominal pain
- Nausea and vomiting (may be feculent)
- Partial or complete bowel obstruction
- Chronic amebic colitis:
- Mild recurrent episodes of bloody diarrhea, abdominal cramping, and tenesmus
- Weight loss
- May persist for years
- Extraintestinal disease:
- Amebic liver abscess:
- Most frequent extraintestinal manifestation (3-9% of cases)
- Single abscess in right lobe (50-80%)
- May develop months to years postexposure (median of 3 mo)
- Fever
- Right upper quadrant pain
- Hepatomegaly with point tenderness
- Rales at right lung base
- Concurrent diarrhea unusual (20-33%)
- Complication: Rupture into pleural cavity (10-20%), peritoneum, or pericardium (rare)
- Increased risk of rupture if >5 cm in diameter or left lobe location
- Extrahepatic amebic abscess:
- Brain
- Lung
- Perinephric
- Splenic
- Vaginal/cervical/uterine
- Cutaneous amebiasis:
- Perineum and genitalia
- Painful, irregularly shaped ulcers
- Purulent exudate
Fulminant colitis is more likely
Fulminant colitis is more likely
History
- Possible sources of exposure
- Membership in high-risk group
Physical Exam
- Identify evidence of peritonitis, sepsis, or shock.
- Tender abdominal mass mandates workup for liver abscess or ameboma.
- Digital rectal exam shows gross or occult blood in >70% of patients.
Diagnosis Tests & Interpretation
Lab
- CBC:
- Leukocytosis in amebic liver abscess and peritonitis
- Alkaline phosphatase and ALT:
- Elevated in amebic liver abscess
- Serum electrolytes, BUN/creatinine if prolonged diarrhea or evidence of dehydration
- Stool PCR is diagnostic gold standard:
- 100% sensitive and specific
- Stool ELISA for E. histolytica-specific antigen:
- 74-95% sensitive, 93-100% specific
- Serum for anti-E. histolytica antibodies:
- Essential if suspecting liver abscess. These patients rarely shed parasites in stool
- 90-100% sensitive in amebic liver abscess
- 70-90% sensitive in amebic colitis
- Stool microscopy is <60% sensitive and no longer the test of choice.
- Fecal leukocytes and culture:
- Rule out infection of enteroinvasive bacteria;
- Negative in amebiasis
Imaging
- Abdominal US:
- 58-90% sensitive for liver abscess
- Sensitivity influenced by size and location
- Evaluate abscess for increased risk of rupture (>5 cm or located in left lobe)
- Abdominal CT or MRI:
- Equivalent to US for delineating liver abscesses
- Superior to US for detecting abscesses in other organs
- Head CT or MRI:
- Suspect amebic brain abscess if patient with known amebiasis has altered mental status or focal neurologic findings.
- Irregular nonenhancing lesions
- CXR:
- Elevated right hemidiaphragm and/or right pleural effusion in liver abscess
Diagnostic Procedures/Surgery
- Colonoscopy with biopsy provides definitive diagnosis of amebic dysentery, colitis, ameboma, and amebic stricture.
- Percutaneous fine-needle aspiration of liver abscess to exclude bacterial abscess if nondiagnostic serology or antiamebic therapy fails
- Not for primary treatment of liver abscesses
Differential Diagnosis
- Intestinal amebiasis:
- Enteroinvasive bacterial infection (Staphylococcus, E. coli, Shigella, Salmonella, Yersinia, Campylobacter)
- Inflammatory bowel disease
- Ischemic colitis
- Arteriovenous malformation
- Abdominal aortic aneurysm
- Perforated duodenal ulcer
- Intussusception, diverticulitis
- Pancreatitis
- Colorectal carcinoma
- Amebic abscess:
- Bacterial abscess
- Tuberculous cavity
- Echinococcal cyst
- Malignancy
- Cholecystitis
- Cutaneous amebiasis:
- Carcinoma
- STDs (condyloma acuminata, chancroid, syphilis)
Treatment
Initial Stabilization/Therapy
- Airway, breathing, circulation (ABCs)
- IV 0.9% NS if signs of significant shock
Ed Treatment/Procedures
- Oral fluids if mild; IV if moderate/severe dehydration
- Avoid antidiarrheal agents.
- Correct serum electrolyte imbalances.
- Stool sample for E. histolytica PCR or ELISA, plus serology for anti-E. histolytica antibodies
- If stool or serum is positive for E. histolytica:
- Metronidazole or tinidazole is 1st-line drug for systemic amebiasis (90% cure rate)
- Chloroquine is an alternative systemic agent
- Always follow systemic therapy with a luminal agent to eradicate intestinal colonization (erythromycin, iodoquinol, nitazoxanide, paromomycin, or tetracycline).
- Do not use the luminal agents alone
- If stool or serum is negative for E. histolytica:
- Refer to gastroenterologist for colonoscopy with biopsy.
- Repeat serology in 7 days.
- Consider empiric course of metronidazole if high suspicion for amebiasis and patient is critically ill.
- If evidence of peritonitis or sepsis:
- Add IV antibiotic directed against anaerobic and gram-negative bacteria.
- Surgery if toxic megacolon or perforation
- If liver abscess is suspected:
- US or CT of hepatobiliary system with concurrent amebic serology
- If imaging demonstrates an abscess but serology is negative, treat with amebicides and repeat serology in 7 days.
- Consider abscess drainage by surgeon or interventional radiologist in conjunction with amebicidal therapy.
- If symptoms do not improve after 5-7 days of empiric amebicidal therapy, consider fine-needle aspiration to rule out bacterial abscess or hepatoma.
- Use metronidazole with caution in 1st-trimester pregnancy, but do not withhold if patient has fulminant colitis or amebic abscess.
- Use erythromycin or nitazoxanide as intestinal amebicides along with metronidazole.
- Erythromycin or nitazoxanide may be used alone for mild dysentery in 1st-trimester pregnancy.
- Chloroquine, iodoquinol, paromomycin, tetracycline, and tinidazole are contraindicated.
Medication
First Line
- Metronidazole: 500-750 mg (peds: 30-50 mg/kg/24 h) PO/IV q8h for 5-10 d
- Tinidazole: 2 g/d (peds: 50-60 mg/kg/d) PO for 3-6 d. For children older than 3 yr
Second Line
- Chloroquine: 1,000 mg/d PO for 2 d then 500 mg/d PO for 14 d; or 200 mg IM for 10-12 d
- Erythromycin: 250-500 mg (peds: 30-50 mg/kg/24 h) PO q6h for 10-14 d
- Iodoquinol: 650 mg PO q8h for 20 d
- Nitazoxanide: 500 mg PO q12. for 3 d (10 d if liver abscess) for children >12 yr
- Paromomycin: 500 mg (peds: 25-30 mg/kg/24 h) PO q8h for 5-10 d
- Tetracycline: 250-500 mg (peds[>12 yr]: 25-50 mg/kg/24 h) PO q6h for 10 d
- Chloroquine and iodoquinol are contraindicated.
- Tetracycline contraindicated in children <8 yr
Use erythromycin or nitazoxanide only.
Follow-Up
Disposition
Admission Criteria
- Shock, sepsis, or peritonitis
- Hypotension or tachycardia unresponsive to IV fluids
- Children with >10% dehydration
- Severe electrolyte imbalance
- Patients unable to maintain adequate oral hydration:
- Extremes of age, cognitive impairment, significant comorbid illness
- Fulminant colitis or toxic megacolon
- Bowel obstruction
- Extraintestinal abscesses
- Failure of outpatient regimen
Discharge Criteria
- Nontoxic presentation of acute or chronic dysentery
- Able to maintain adequate oral hydration and medication compliance
- Dehydration responsive to IV fluids
Issues for Referral
Consult surgery if evidence of peritonitis, toxic megacolon, colonic perforation, or liver abscess.
Follow-Up Recommendations
- Gastroenterology and infectious disease follow-up in 7 days for repeat serology and possible endoscopic evaluation.
- Physical exam in 14 days to assess for treatment effectiveness and for development of complications or extraintestinal disease.
Pearls and Pitfalls
- Avoid antidiarrheal medications
- Always give double therapy with both a systemic amebicidal (metronidazole, tinidazole, or chloroquine) plus an intestinal amebicidal (erythromycin, iodoquinol, nitazoxanide, paromomycin, or tetracycline) unless contraindicated.
- Always be vigilant for high-mortality complications such as fulminant colitis or extraintestinal disease.
Additional Reading
- Chavez-Tapia NC, Hernandez-Calleros J, Tellez-Avila FI, et al. Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess. Cochrane Database Syst Rev. 2009;1:CD004886. doi:10.1002/14651858.CD004886.pub2.
- Escobedo AA, Almirall P, Alfonso M, et al. Treatment of intestinal protozoan infections in children. Arch Dis Child. 2009;94:478-482.
- Fotedar R, Stark D, Beebe N, et al. Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev. 2007;20:511-532.
- Gonzalez MLM, Dans LF, Martinez EG. Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev. 2009;2:CD006085. doi:10.1002/14651858.CD006085.pub2.
See Also (Topic, Algorithm, Electronic Media Element)
Codes
ICD9
- 006.0 Acute amebic dysentery without mention of abscess
- 006.1 Chronic intestinal amebiasis without mention of abscess
- 006.9 Amebiasis, unspecified
- 006.8 Amebic infection of other sites
- 006.2 Amebic nondysenteric colitis
- 006.3 Amebic liver abscess
- 006.4 Amebic lung abscess
- 006.5 Amebic brain abscess
- 006.6 Amebic skin ulceration
- 006 Amebiasis
ICD10
- A06.0 Acute amebic dysentery
- A06.1 Chronic intestinal amebiasis
- A06.9 Amebiasis, unspecified
- A06.89 Other amebic infections
- A06.2 Amebic nondysenteric colitis
- A06.3 Ameboma of intestine
- A06.4 Amebic liver abscess
- A06.5 Amebic lung abscess
- A06.6 Amebic brain abscess
- A06.7 Cutaneous amebiasis
- A06.81 Amebic cystitis
- A06.82 Other amebic genitourinary infections
- A06.8 Amebic infection of other sites
- A06 Amebiasis
SNOMED
- 111910009 Amebic infection (disorder)
- 186116005 Acute amebic dysentery (disorder)
- 23874000 Chronic amebiasis (disorder)
- 238449000 Amebiasis of skin (disorder)
- 406559005 Amebic infection of central nervous system
- 65095005 Amebic lung abscess
- 75119003 Amebic liver abscess (disorder)